Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06596668
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-11
Brief Title:
Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants MK-3543-020
Sponsor:
None
Organization:
None
Study Overview
Official Title:
An Open-Label Phase 1 Study to Characterize the Effects of a Strong Cytochrome P450 3A4 Inducer on the Pharmacokinetics of Bomedemstat in Healthy Adult Participants
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Researchers have designed a study medicine called bomedemstat MK-3543 as a new way to treat certain rare blood diseases
The purpose of this study is to learn what happens to bomedemstat in a persons body over time a pharmacokinetic or PK study Researchers will compare what happens to bomedemstat in the body when it is given alone and after multiple doses of another medicine called carbamazepine CBZ
The purpose of this study is to learn what happens to bomedemstat in a persons body over time a pharmacokinetic or PK study Researchers will compare what happens to bomedemstat in the body when it is given alone and after multiple doses of another medicine called carbamazepine CBZ
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None